ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®

NEXT STORY
BioAegis Therapeutics Announces Publication in the Journal of Infectious Diseases: “Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Penicillin-Sensitive and Resistant Pneumococcal Pneumonia”
PREV STORY
Global Precision Medicine Market Expected To Reach over USD 86.25 Billion By 2025: Zion Market Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Myriad Announces GeneSight® Psychotropic Results from a Large Prospective Trial in Patients with Major Depressive Disorder

SALT LAKE CITY, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary ...

author_avatar
NASDAQ Market News

After the storm: keeping your pet safe after a hurricane

SEATTLE, Sept. 08, 2017 (GLOBE NEWSWIRE) -- Recovery after a hurricane takes time. Depending ...

author_avatar
NASDAQ Market News

XBiotech to Present at Cantor Fitzgerald’s Global Healthcare Conference

AUSTIN, Texas, Sept. 21, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that ...

author_avatar
NASDAQ Market News